Oncology Nurses as Patient Advocates

Article

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other members of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

Oncology nurses can make the world of a difference when it comes to patient care, and it is crucial that they work together with other memebers of the treatment team to ensure the best outcomes, according to Sally Werner, MSHA, BSN, RN, senior vice president, affiliate relations at Cancer Support Community.

In this month’s episode of the CURE Talks Cancer Podcast: Nursing Edition, Werner — an oncology nurse by trade – discusses how nurses can be the best advocates for their patients, how to navigate life in the era of “Dr. Google,” and more.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with blonde hair wearing a denim jacket in front of a blue background
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Related Content
Graphic reading "FDA Approved" resembling a stamp of approval

Ready-to-Dilute Thiotepa Approved for Breast and Ovarian Adenocarcinomas

Bridget Hoyt
April 29th 2025
Article

A ready-to-dilute formulation of thiotepa has been approved by the FDA for use in breast and ovarian cancers.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Photo of a young woman shaking hands with a healthcare provider in a doctor's office

Opinion: Increasing Support and Awareness for AYAs With Cancer

Hayley Feuchs, LMSW
April 28th 2025
Article

AYA Cancer Awareness Month offers an opportunity for nurses to go further in supporting AYAs with cancer.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Image of bone marrow cells

As-Expected Ruxolitinib Starting Dose Outperforms Lower Dosage in Myelofibrosis

Bridget Hoyt
April 25th 2025
Article

Both those receiving either expected or less-than-expected starting dosages of ruxolitinib for myelofibrosis treatment reduced daily dosages over 12 months.

Graphic image of a blue brain on a blue background

Breakthrough Designation Granted to BCB-276 for Pediatric DIPG

Chris Ryan
April 25th 2025
Article

Findings from the phase 1 BrainChild-03 trial support breakthrough designation for BCB-276 for pediatric diffuse intrinsic pontine glioma.